255 results found.
3Q14 Revenue: Globus Medical
$117.8MM, +10% (U.S. +9%, ex-U.S. +23%) Innovative Fusion $67.7MM, +8% Disruptive Technologies $50.1MM, +12%   Expanded rollout of CREO next-gen pedicle screw platform, launched SILC low-profile sublaminar fixation syst...
BARE BONES® - October 23, 2014
Globus Medical acquired Transplant Technologies of Texas, provider of human tissue products including bone allografts, biomaterials and soft tissue products for spine, orthopaedics, sports medicine and other a...
BARE BONES® - October 10, 2014
Globus Medical launched SILC™, a low-profile sublaminar fixation system for correction of spinal curvatures, without the need for pedicle purchase in all vertebrae. (
BARE BONES® - August 6, 2014
Globus Medical reported 2Q14 sales of US $113.6MM, +6.1% from 2Q13. (U.S. +3.6%, ex-U.S. +34.1%) (
2Q14 Revenue: Globus Medical
$113.6MM, +6% (U.S. $101.6MM, +4%; ex-U.S. $11.9MM, +34%) Innovative Fusion $65.8MM, +5% Disruptive Technology $47.7MM, +8%   Low U.S. sales growth attributed to nonrenewal of contract with significant U.S. distributor,...
BARE BONES® - May 29, 2014
Globus Medical launched the MONUMENT™ anterior lumbar interbody fusion device, featuring a self-locking and threaded translational feature that can reduce the implant up to 8mm
BARE BONES® - April 29, 2014
Globus Medical reported 1Q14 sales of US $114.2MM, +8.8% from 1Q13. (U.S. +5.6%, ex-U.S. +43%) (
1Q14 Revenue: Globus Medical
$114.2MM, +9% (U.S. $101.7MM, +6%; ex-U.S. $12.5MM, +43%) Innovative Fusion $66.8MM, +9% Disruptive Technology $47.4MM, +9%   Growth impacted by severe U.S .weather Price pressure remains in low- to mid-s...
4Q13/2013 Revenue: Bacterin
4Q13 tissue revenue: $8.3MM, +2% 2013 tissue revenue: $33.1MM, flat Business model going forward: direct sales to orthopaedics and neurosurgery via hybrid model; exploring private label relationships Increased productivity: 25 sal...
BARE BONES® - February 27, 2014
Globus Medical posted 4Q13 sales of US $115.2MM, +14.6% from 4Q12, and 2013 sales of $434.5MM, +12.6% vs. 2012. (
4Q13/2013 Revenue: Globus Medical
4Q13 revenue: $115.2MM, +15% (U.S. $104.1MM, +13%; ex-U.S. $11.1MM, +29%) Innovative Fusion $67.1MM, +15% Disruptive Technology $48.1MM, +14%   CREO pedicle screw + increased reps supported growth ...
4Q13/2013 Revenue: Mazor Robotics
4Q13 revenue: $5.7MM, +111% (U.S. $4.2MM, +200%; ex-U.S. $1.5MM, +15%) 2013 revenue: $20.0MM, +64% Sold 23 systems globally; installed base now 63 (34 in U.S.) 65% of spine cases using Renaissance were multi-level/complex, with 1/...
BARE BONES® - January 14, 2014
Globus Medical announced preliminary 4Q13 sales of US $115.2MM, +14.6% vs. 4Q12, and preliminary 2013 sales of $434.5MM, +12.6% from 2012. (
BARE BONES® - January 9, 2014
Globus Medical (GMED) acquired Excelsius Surgical, developer of a next-generation surgical robotic positioning platform for spine and other applications. The robotic Excelsius Surgical system supports navigation, surgi...
2013: Who, What, Where and When in an Orthopaedic Year
Before we dive into 2014, let’s review what 2013 wrought. We’ve collected the start-ups, expansions and closures, mergers and acquisitions, fundings, first 510(k)s and products launched across the orthopaedic universe in the preceding 12 months. (Please note, start-ups, first 510(k...
BARE BONES® - December 24, 2013
Globus Medical was assigned U.S. Patent No. 8,613,759, titled “Transverse fixation device for spinal fixation systems.” (
BARE BONES® - October 31, 2013
Globus Medical posted 3Q13 sales of US $107.2MM, +13% from 3Q12. (U.S. +13%, ex-U.S. +19%) (
3Q13 Revenue: Globus Medical
$107.2MM, +13% (U.S. $98.1MM, +13%; ex-U.S. $9.1MM, +19%) Disruptive Technology $45MM, +21% Innovative Fusion $63MM, +8%   Pricing pressure remains in low to middle single digits Payor pushback seems to h...
BARE BONES® - October 15, 2013
Globus Medical (GMED) received an FDA Warning Letter, dated 9/27/13, citing deficiencies in response to observations relative to MicroFuse® putty, cl...
Web Exclusive: Highlights from THE SPINE MARKET report
In 2012, revenues generated by global sales of spinal implants and instrumentation reached an estimated $7.35 billion. Though historic double-digit growth in the segment flattened in 2010, looking ahead, conservative increases should occur based upon a shift in focus to more cervical discs, la...
BARE BONES® - October 3, 2013
Globus Medical announced launch of the CREO™ next generation pedicle screw platform. CREO pedicle screws are available in modular and pre-assembled versions with top-loading, side loading
BARE BONES® - August 1, 2013
Globus Medical reported 2Q13 sales of US $107MM, +12% from 2Q12. (U.S. +11%, ex-U.S. +20%) (
2Q13 Revenue: Globus Medical
$107MM, +12% (U.S. $98.1MM, +11%; ex-U.S. $8.9MM, +20%) Disruptive Technology $44MM, +27% Innovative Fusion $63MM, +3%   Payer pushback appears to have stabilized Pricing pressure remains in low- to mid-s...
BARE BONES® - June 21, 2013
Globus Medical commenced launch of the LATIS™ minimally invasive lumbar interbody fusion spacer for the treatment of degenerative disc disease. Inserted through an MIS transforaminal approach
BARE BONES® - June 17, 2013
A Federal jury awarded DePuy Synthes US $16MM in damages in a patent infringement trial vs. Globus Medical (GMED). The jury also determined the validity of DePuy Synthes' U.S. Patents No.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2020 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group